Cargando…
Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon
BACKGROUND: The mechanisms underlying altered susceptibility and propensity to severe Coronavirus disease 2019 (COVID-19) disease in at-risk groups such as patients with chronic obstructive pulmonary disease (COPD) are poorly understood. Inhaled corticosteroids (ICSs) are widely used in COPD, but th...
Autores principales: | Finney, Lydia J., Glanville, Nicholas, Farne, Hugo, Aniscenko, Julia, Fenwick, Peter, Kemp, Samuel V., Trujillo-Torralbo, Maria-Belen, Loo, Su Ling, Calderazzo, Maria Adelaide, Wedzicha, Jadwiga A., Mallia, Patrick, Bartlett, Nathan W., Johnston, Sebastian L., Singanayagam, Aran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mosby
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558236/ https://www.ncbi.nlm.nih.gov/pubmed/33068560 http://dx.doi.org/10.1016/j.jaci.2020.09.034 |
Ejemplares similares
-
Inflammation and infections in unreported chronic obstructive pulmonary disease exacerbations
por: Calderazzo, Maria Adelaide, et al.
Publicado: (2019) -
Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations
por: Singanayagam, Aran, et al.
Publicado: (2018) -
Airway mucins promote immunopathology in virus-exacerbated chronic obstructive pulmonary disease
por: Singanayagam, Aran, et al.
Publicado: (2022) -
Effect of CRTH2 antagonism on the response to experimental rhinovirus infection in asthma: a pilot randomised controlled trial
por: Farne, Hugo, et al.
Publicado: (2022) -
Antiviral immunity is impaired in COPD patients with frequent exacerbations
por: Singanayagam, Aran, et al.
Publicado: (2019)